Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|November 3, 2004
Thalidomide in solid tumours: the resurrection of an old drugStefan Sleijfer, Wim H J Kruit, Gerrit StoterJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxelCarolien H Smorenburg, Alex Sparreboom, Marijke Bontenbal, et al.Pharmacy World & Science : PWS|December 13, 2005
Side effects of interferon-alpha therapyStefan Sleijfer, Marjolein Bannink, Arthur R Van Gool, et al.European Journal of Cancer (Oxford, England : 1990)|March 2, 2005
The potential of statins as part of anti-cancer treatmentStefan Sleijfer, Ate van der Gaast, André S Th Planting, et al.Biochemical and Biophysical Research Communications|September 10, 2003
Functional cloning of drug resistance genes from retroviral cDNA librariesPeter T Bosma, Simone J van Eert, Nicolaas G J Jaspers, et al.Molecular Pharmacology|February 21, 2002
Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotypePaul W Schenk, Antonius W M Boersma, Mariël Brok, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Impact of body-size measures on irinotecan clearance: alternative dosing recommendationsRon H J Mathijssen, Jaap Verweij, Maja J A de Jonge, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 1, 2002
Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatographyWalter J Loos, Desirée M van Zomeren, Hans Gelderblom, et al.Cancer Immunology, Immunotherapy : CII|March 22, 2003
IL-12: a promising adjuvant for cancer vaccinationJohanna E A Portielje, Jan Willem Gratama, Heidi H van Ojik, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxelHans Gelderblom, Jaap Verweij, Desirée M van Zomeren, et al.Pageof 4